Author

P. C. DeMuth

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Jakubowski· 3 shared C. M. Haqq· 3 shared L. M. Seenappa· 3 shared M. P. Steinbuck· 3 shared L. K. McNeil· 2 shared A. M. Abbas· 1 shared C. Carter· 1 shared D. J. Drakes· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. Jakubowski

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Programming the lymph node immune response with Amphiphile-CpG induces potent cellular and humoral immunity following COVID-19 subunit vaccination in mice and non-human primates

L. M. Seenappa, A. Jakubowski, M. P. Steinbuck, E. Palmer, C. M. Haqq, C. Carter, J. Fontenot, F. Villinger, L. K. McNeil, P. C. DeMuth

This study evaluates an AMP-CpG adjuvant in combination with SARS-CoV-2 RBD as a subunit vaccine, showing enhanced T cell and cross-reactive antibody responses in mice and NHPs.

bioRxiv · May 19, 2022 · PreprintImmunology

Lymph node-targeted vaccine boosting of TCR-T cell therapy enhances anti-tumor 1 function and eradicates solid tumors

D. J. Drakes, A. M. Abbas, J. Shields, M. P. Steinbuck, A. Jakubowski, L. M. Seenappa, C. M. Haqq, P. C. DeMuth

This paper shows that combining AMP-vaccination with TCR-T cell therapy improves T cell persistence and anti-tumor activity, leading to solid tumor eradication in mice.

bioRxiv · May 5, 2022 · PreprintImmunology

A Lymph Node Targeted Amphiphile Vaccine Induces Potent Cellular and Humoral Immunity to SARS-CoV-2

M. P. Steinbuck, L. M. Seenappa, A. Jakubowski, L. K. McNeil, C. M. Haqq, P. C. DeMuth

This study evaluates a novel amphiphile vaccine adjuvant, AMP-CpG, which induces strong cellular and humoral immunity against SARS-CoV-2 in mice.

bioRxiv · Aug 17, 2020Immunology